Verana Health, Bitfount Partner to Streamline Ophthalmic Clinical…

Event summary

Verana Health partners with Bitfount to accelerate ophthalmic clinical trial prescreening using AI-driven analysis of imaging and EHR data.
Combined solution clinically validated in a study with Moorfields Eye Hospital, improving speed and accuracy of patient identification.
Verana Health leverages exclusive access to 12+ years of longitudinal ophthalmology data from 90M+ de-identified patients.
Prescreening results integrated into Verana Trail Connect (VTC) and Bitfount’s on-premise application for HIPAA-compliant access.

The big picture

This partnership addresses a critical bottleneck in ophthalmic clinical trials—patient prescreening—by combining Verana Health’s real-world data with Bitfount’s AI imaging analysis. The collaboration aims to reduce costly delays and mismatched enrollments, aligning with broader industry shifts toward data-driven, efficient trial designs. With exclusive access to one of the largest ophthalmology datasets, Verana Health is positioning itself as a key player in accelerating therapeutic development for eye diseases.

What we're watching

Adoption Pace: How quickly participating sites integrate the combined prescreening solution into existing workflows.
Data Privacy: Whether the federated AI analysis model maintains robust data privacy without disrupting existing infrastructure.
Competitive Response: How traditional clinical trial management platforms react to this AI-driven prescreening innovation.